期刊文献+

张之文辨治特发性肺纤维化经验探析 被引量:7

Discussion on ZHANG Zhi-wen's experience in the treatment of idiopathic pulmonary fibrosis
原文传递
导出
摘要 首届全国名中医张之文教授认为,特发性肺纤维化属虚实夹杂、本虚标实疾病。本虚从寒热来看,分虚热与虚寒两类,病位在肺,主要涉及脾、胃、肾等脏腑;标实早期以肺络瘀阻为主,继续发展则表现为痰瘀阻滞证候,晚期出现瘀毒内盛证候;瘀血为患贯穿本病始终,化瘀宜早不宜迟。本病早期可见肺胃两虚兼络脉受损证型,继续发展可见肺脾气虚兼痰瘀互结证型,晚期多见肺肾虚衰兼瘀毒为患证型。文章总结张教授治疗特发性肺纤维化临证经验及用药特色,通过典型病案分析张教授的证治思路。 In the view of professor ZHANG Zhi-wen, the first national famous doctors of traditional Chinese medicine, idiopathic pulmonary fibrosis(IPF) is a disease with intermingled deficiency and excess, the pathogenesis of which is deficiency in origin and excess in superficiality. Based on the differences of cold-syndrome and heat-syndrome, the deficiency is divided into two types: deficiency-heat syndrome and deficiency-cold syndrome. The site of IPF is lung, and related closely with spleen, stomach and kidney. Excess is mainly of collaterals in the lung in the early stage of symptom. With the development of the disease, it was manifested as the syndrome of blockade of phlegm and static blood, and later appeared as the internal exuberance of stasis-toxin syndrome. Blood stasis persists throughout the disease, and measures of promoting blood circulation to remove blood stasis should be taken as early as possible. In the early stage of the disease, the syndrome of deficiency of lung and stomach and collateral damage can be seen. The syndrome of qi deficiency of lung and spleen and phlegm-blood stasis can be seen with the development of the disease. Deficiency of lung and kidney and stasis-toxin were more common in the late stage. This paper summarized professor ZHANG’s clinical experience and medication characteristics in the treatment of IPF, and discussed professor ZHANG’s thoughts in symptom and treatment through typical medical records.
作者 栗林杰 冯全生 郑秀丽 叶桦 LI Lin-jie;FENG Quan-sheng;ZHENG Xiu-li;YE Hua(Chengdu University of TCM,Chengdu 611137,China)
出处 《中华中医药杂志》 CAS CSCD 北大核心 2021年第3期1442-1445,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家重点研发计划中医药现代化研究(No.2018YFC1704104) 四川省社会科学重点研究基地项目(No.2020C17) 四川省高等学校人文社会科学重点研究基地项目(No.ZYYWH1929) 国家中医药管理局中医药传承与创新“百千万”人才工程(No.003109011004) 成都中医药大学校基金(No.MIEC1804)
关键词 特发性肺纤维化 临证经验 用药特色 张之文 Idiopathic pulmonary fibrosis(IPF) Clinical experience Medication characteristics ZHANG Zhi-wen
  • 相关文献

参考文献8

二级参考文献45

共引文献245

同被引文献189

引证文献7

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部